HomeCompareHTA vs CHD

HTA vs CHD: Dividend Comparison 2026

HTA yields 35.62% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HTA wins by $491.1K in total portfolio value
10 years
HTA
HTA
● Live price
35.62%
Share price
$29.19
Annual div
$10.40
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$517.5K
Annual income
$151,314.29
Full HTA calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — HTA vs CHD

📍 HTA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTACHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTA + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTA pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTA
Annual income on $10K today (after 15% tax)
$3,027.91/yr
After 10yr DRIP, annual income (after tax)
$128,617.15/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, HTA beats the other by $127,518.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTA + CHD for your $10,000?

HTA: 50%CHD: 50%
100% CHD50/50100% HTA
Portfolio after 10yr
$271.9K
Annual income
$76,303.39/yr
Blended yield
28.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

HTA
Analyst Ratings
10
Buy
13
Hold
Consensus: Hold
Altman Z
2.5
Piotroski
6/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTA buys
0
CHD buys
0
No recent congressional trades found for HTA or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTACHD
Forward yield35.62%1.27%
Annual dividend / share$10.40$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR8.6%23.1%
Portfolio after 10y$517.5K$26.4K
Annual income after 10y$151,314.29$1,292.51
Total dividends collected$436.5K$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: HTA vs CHD ($10,000, DRIP)

YearHTA PortfolioHTA Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$14,569$3,868.60$10,856$156.32+$3.7KHTA
2$21,309$5,720.28$11,811$195.24+$9.5KHTA
3$31,292$8,491.85$12,883$244.38+$18.4KHTA
4$46,139$12,656.88$14,091$306.64+$32.0KHTA
5$68,311$18,941.32$15,463$385.88+$52.8KHTA
6$101,555$28,462.40$17,033$487.17+$84.5KHTA
7$151,610$42,946.69$18,843$617.36+$132.8KHTA
8$227,296$65,073.51$20,947$785.72+$206.3KHTA
9$342,225$99,018.07$23,419$1,004.91+$318.8KHTA
10$517,495$151,314.29$26,350$1,292.51+$491.1KHTA

HTA vs CHD: Complete Analysis 2026

HTAStock

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 25.1 million square feet of GLA, with $7.4 billion invested primarily in MOBs. HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations. Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth. The strategic markets HTA invests in support a strong, long-term demand for quality medical office space. HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market. This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation. Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level. Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.

Full HTA Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this HTA vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTA vs SCHDHTA vs JEPIHTA vs OHTA vs KOHTA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.